Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-3-14
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0026-4075
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
viii
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9002694-Africa,
pubmed-meshheading:9002694-Antimalarials,
pubmed-meshheading:9002694-Doxycycline,
pubmed-meshheading:9002694-Humans,
pubmed-meshheading:9002694-Malaria,
pubmed-meshheading:9002694-Mefloquine,
pubmed-meshheading:9002694-Military Personnel,
pubmed-meshheading:9002694-United States
|
pubmed:year |
1997
|
pubmed:articleTitle |
Doxycycline vs. mefloquine.
|
pubmed:publicationType |
Letter
|